Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.910087
Abstract: Germ cell tumors are the most common malignant tumors in male young adults. Platinum-based chemotherapy has dramatically improved the outcome of metastatic germ cell tumor patients and overall cure rates now exceed 80%. The choice… read more here.
Keywords: prediction patients; inflammatory biomarkers; outcome prediction; biomarkers outcome ... See more keywords